---
title: "VSee Health Secures New Note Purchase Agreement"
description: "VSee Health, Inc. has entered a note purchase agreement with an institutional investor, issuing a secured note of $133,333.33 at a purchase price of $120,000, with a 5% interest rate, maturing on May "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260602522.md"
published_at: "2025-10-10T10:30:19.000Z"
---

# VSee Health Secures New Note Purchase Agreement

> VSee Health, Inc. has entered a note purchase agreement with an institutional investor, issuing a secured note of $133,333.33 at a purchase price of $120,000, with a 5% interest rate, maturing on May 8, 2026. The agreement includes restrictions on variable rate transactions and mandates equal terms for future debt holders. Analysts rate VSEE stock as a Sell with a $0.50 price target, citing financial instability and risks of Nasdaq delisting, despite some revenue growth. VSee Health focuses on telemedicine solutions and has a current market cap of $11.01M.

The latest announcement is out from VSee Health ( (VSEE) ).

On October 9, 2025, VSee Health, Inc. entered into a note purchase agreement with an accredited institutional investor, issuing a secured note for $133,333.33 with a purchase price of $120,000, bearing an interest rate of 5% per annum and maturing on May 8, 2026. The agreement includes restrictions on variable rate transactions and mandates equal terms for future debt holders, while an amendment agreement ensures the note is fully secured by the company’s assets, potentially strengthening VSee Health’s financial stability and market position.

The most recent analyst rating on (VSEE) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.

**Spark’s Take on VSEE Stock**

According to Spark, TipRanks’ AI Analyst, VSEE is a Underperform.

VSee Health’s overall stock score is heavily impacted by financial instability and the risk of Nasdaq delisting. While there is some revenue growth, the negative equity, poor valuation, and bearish technical indicators contribute to a low score.

To see Spark’s full report on VSEE stock, click here.

**More about VSee Health**

VSee Health, Inc. operates in the healthcare industry, focusing on telemedicine solutions and digital health services.

**Average Trading Volume:** 477,779

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $11.01M

For a thorough assessment of VSEE stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [VSEE.US - VSee Health](https://longbridge.com/en/quote/VSEE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| VSee Health Hosts Webinar Showcasing Scalable Tele-Urgent Care Solutions | VSee Health Inc. hosted a webinar with Novant Health Urgent Care, featuring Dr. Milton Chen and Natalie Condé. They disc | [Link](https://longbridge.com/en/news/268617626.md) |
| VSee Health Secures New Note Purchase Agreement | VSee Health has announced a note purchase agreement with an accredited institutional investor, issuing a secured note of | [Link](https://longbridge.com/en/news/261944073.md) |
| Arrive AI Showcases Autonomous Delivery Infrastructure Powered by Arrive Points(TM) at India AI Impact Summit 2026 | Arrive AI showcased its AI-powered autonomous delivery infrastructure, Arrive Points™, at the India AI Impact Summit 202 | [Link](https://longbridge.com/en/news/276084697.md) |
| EQT's Proposed New Chairman Jean Eric Salata Purchases Shares Worth SEK 152 Million | On February 10, Jean Eric Salata purchased 500,000 shares of EQT for SEK 152.1 million through Maximus Elm Investments H | [Link](https://longbridge.com/en/news/275855969.md) |
| The AI stocks to sell immediately and the ones to buy instead | Tom Yeung discusses AI stocks, advising on which to sell and which to buy. He uses a Boston tradition as a metaphor for  | [Link](https://longbridge.com/en/news/275797000.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.